Acetylcholine receptor-reactive antibody induces nitric oxide production by a rat skeletal muscle cell line: Influence of cytokine environment

Journal of Neuroimmunology

Volumn 120, Issue 1-2, 2001, Pages 103-111

  Garcia, Yvonne R ^a   May, Jennifer J ^a   Green, Alicia M ^a   Krolick, Keith A ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Autoimmune disease; Experimental autoimmune myasthenia gravis; Inflammatory cytokines; Nitric oxide synthase

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 4; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 35; NERVE CELL ADHESION MOLECULE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME SYNTHESIS; GENE EXPRESSION; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MUSCLE CELL; MYASTHENIA GRAVIS; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SKELETAL MUSCLE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, MONOCLONAL; CELL DIVISION; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; INTERFERON TYPE II; INTERLEUKIN-1; MUSCLE, SKELETAL; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED LEW; RECEPTORS, CHOLINERGIC; RNA, MESSENGER; STEM CELLS; T-LYMPHOCYTES; UP-REGULATION;

EID: 0034750868     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00414-3     Document Type: Article

References (52)

1. Interferon (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice
2. Induction of diaphragmatic nitric oxide synthase after endotoxin administration in rats
3. Endogenous peroxynitrite mediates mitochondrial dysfunction in rat diaphragm during endotoxemia
4. The role of nitric oxide in inflammation and immunity
5. Nitric oxide is a potential down-regulating molecule in autoimmune disease: Inhibition of nitric oxide production renders PVG rats highly susceptible to EAE
6. Myasthenia gravis
7. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis
8. Human myoblasts as antigen presenting cells
9. Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction
10. Nitric-oxide synthase assays
11. Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism
12. Experimental myasthenia: Lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates
13. Disruption of the IL-1beta gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis
14. Interleukin 4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor
15. Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice
16. Cloning of an inducible nitric oxide synthase from rat
17. Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value
18. Myasthenia gravis
19. Organ-specific autoantigens induce interferon-gamma and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis
20. Modulation of MHC Class II antigen expression in human myoblasts after treatment with IFN-gamma
21. Effects of nitric oxide on the contraction of skeletal muscle
22. Role of nitric oxide in depressed lymphoproliferative responses and altered cytokine production following thermal injury in rats
23. Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes
24. Epitopes on the beta subunit of human muscle acetylcholine receptor recognized by CD4+ cells of myasthenia gravis patients and healthy subjects
25. Myasthenia gravis. Residues of the alpha and gamma subunit of the acetylcholine receptor involved in formation of immunodominant CD4+ epitopes
26. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease
27. Tumor necrosis factor α and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon γ stimulation
28. Selective in vitro inhibition of an antibody response to purified acetylcholine receptor using antigen-rich A chain Immunotoxin
29. Analysis of contractile properties of muscles from rats immunized with purified acetylcholine receptor
30. Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis
31. Chemokine production by rat myocytes exposed to interferon-gamma
32. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and IL-10 relates to resistance to experimental autoimmune myasthenia gravis (EAMG) in young Lewis rats
33. Interleukin-12 enhances clinical experimental autoimmune myasthenia gravis in susceptible but not resistant mice
34. A monoclonal Lewis rat myocyte line that responds to interferon-gamma: Responsiveness with the potential to influence subsequent interactions with the immune system
35. Myocytes respond to both interleukin-4 and interferon-gamma: Cytokine responsiveness with the potential to influence the severity and course of experimental myasthenia gravis
36. Cytokine responsiveness by and lymphocyte trafficking through rat skeletal muscle following passive of antibody reactive with the acetylcholine receptor
37. Interleukin-12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis
38. Acetylcholine receptor-reactive antibodies in experimental autoimmune myasthenia gravis differing in disease-causing potential: Subsetting by preparative isoelectric focusing
39. Humoral immunity in myasthenia gravis: Clinical correlations of anti-receptor antibody avidity and titer
40. Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor
41. Th1 epitope repertoire on the alpha subunit of human muscle acetylcholine receptor in myasthenia gravis
42. T cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis
43. Myasthenia in SCID mice grafted with myasthenic patient lymphocytes: Role of CD4+ and CD8+ cells
44. IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: A possible role for nitric oxide
45. Mechanisms of recovery from experimental allergic encephalomyelitis induced with myelin basic protein peptide 68-86 in Lewis rats: A role for dendritic cells in inducing apoptosis of CD4+ T cells
46. Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression of experimental allergic encephalomyelitis (EAE) in Lewis rats
47. T cells reactive with a small synthetic peptide of the acetylcholine receptor can provide help for a clonotypically heterogeneous antibody response and subsequently impaired muscle function
48. Suppression of experimental autoimmune myasthenia gravis after CD8 depletion is associated with decreased IFN-gamma and IL-4
49. Cytokines and pathogenesis of myasthenia gravis
50. Mice with IFN-γ receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis
51. Antigen presentation and T cell specificity repertoire in determining responsiveness to an epitope important in experimental autoimmune myasthenia gravis
52. Clonotypic analysis of anti-acetylcholine receptor antibodies from EAMG-sensitive Lewis rats and EAMG-resistant Wistar Furth rats